20 December 2024
Welcoming New Editorial Board Members of Cancers
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to announce that five new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694) in 2024. We wish our new members success in both their research and the efforts to develop the journal.
Name: Dr. Leonhard Müllauer
Affiliation: Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria
Interests: molecular pathology; apoptosis; targeted therapy
Name: Dr. Jason Li
Affiliation: Peter Maccallum Cancer Centre, Melbourne, Australia
Interests: bioinformatics; cancer; artificial intelligence; genomics; imaging; large language models; facility management
Name: Prof. Dr. Arun Dharmarajan
Affiliations: 1. School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute (CHIRI), Curtin University, Perth, WA, Australia
2. School of Human Sciences, The University of Western Australia, Nedlands, Perth, WA 6009, Australia
Interests: Wnt signaling; secreted frizzled related protein 4; cancer; cancer stem cells; angiogenesis; apoptosis; redox signaling; molecular modeling
Name: Dr. Francesca Pentimalli
Affiliation: Department of Medicine and Surgery, LUM University Giuseppe DeGennaro, 70010 Casamassima, Italy
Interests: cell cycle; mesothelioma; DNA damage; tumor suppressor genes; RB family; p53; oncolytic viruses; cell death; CDK inhibitors; p27
Name: Prof. Dr. Yicheng Ni
Affiliation: Department of Radiology, Affiliated Zhongda Hospital, Southeast University, Nanjing, China
Interests: imaging-navigated translational theragnostic research
Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.
Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office (cancers@mdpi.com) and provide the following files: